MedTrace Logo

Interpersonal Psychotherapy for Severely Depressed Inpatients

NCT00325000 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-12-20

No results posted yet for this study

Summary

We examined the hypotheses that severely depressed inpatients treated for 5 weeks with IPT-S plus pharmacotherapy have 1) a higher reduction in depressive symptoms and 2) higher response- and remission rates compared to pharmacotherapy plus CM. For the follow-up period (12 months) we hypothesized a better symptomatic and psychosocial longterm outcome and lower rates of relapse for patients initially treated with combination therapy.

Conditions

Interventions

BEHAVIORAL

Interpersonal Psychotherapy

DRUG

sertraline or amitriptyline

Sponsors & Collaborators

  • German Research Foundation

    lead OTHER

Principal Investigators

  • Mathias Berger, MD · University Clinic Freiburg, Dept. of Psychiatry and Psychotherapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Completion
2004-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00325000 on ClinicalTrials.gov